Vigonvita Life Sciences Co., Ltd. (HKG:2630)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
81.80
+1.30 (1.61%)
At close: Dec 30, 2025
-13.89%
Market Cap13.72B
Revenue (ttm)12.59M
Net Income (ttm)-224.97M
Shares Out167.60M
EPS (ttm)-1.55
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume50,400
Average Volume119,012
Open80.50
Previous Close80.50
Day's Range80.00 - 83.20
52-Week Range51.00 - 97.00
Betan/a
RSI54.90
Earnings Daten/a

About Vigonvita Life Sciences

Vigonvita Life Sciences Co., Ltd., a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas. Its lead products include LV232, a first-in-class dual-target serotonin transporter/5-hydroxytryptamine 3 receptor modulators, which is in Phase II of clinical trial for the treatment of depressive disorder; and TPN171, a type-5 phosphodiesterase inhibitor completed Phase III clinical trial for the tre... [Read more]

Industry Pharmaceutical Preparations
Founded 2013
Country China
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2630
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.